F.D.A. Wants More Tests on a Novo Nordisk Insulin, Tresiba
Monday, February 11, 2013 - 05:50
in Health & Medicine
The request by the F.D.A. for more data on the heart risks of a diabetes drug will delay an important product for Novo Nordisk of Denmark.